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Background: Increasing evidence suggests that influenza reassortment not only contributes to the emergence of
new human pandemics but also plays an important role in seasonal influenza epidemics, disease severity, evolution,
and vaccine efficacy. We studied this process within 2091 H3N2 full genomes utilizing a combination of the latest
reassortment detection tools and more conventional phylogenetic analyses.
Results: We found that the amount of H3N2 intra-subtype reassortment depended on the number of sampled
genomes, occurred with a steady frequency of 3.35%, and was not affected by the geographical origins, evolutionary
patterns, or previous reassortment history of the virus. We identified both single reassortant genomes and reassortant
clades, each clade representing one reassortment event followed by successful spread of the reassorted variant in the
human population. It was this spread that was mainly responsible for the observed high presence of H3N2 intra-subtype
reassortant genomes. The successfully spread variants were generally sampled within one year of their formation,
highlighting the risk of their rapid spread but also presenting an opportunity for their rapid detection. Simultaneous
spread of several different reassortant lineages was observed, and despite their limited average lifetime, second and third
generation reassortment was detected, as well as reassortment between viruses belonging to different vaccine-associated
clades, likely displaying differing antigenic properties. Some of the spreading reassortants remained confined to certain
geographical regions, while others, sharing common properties in amino acid positions of the HA, NA, and PB2 segments,
were found throughout the world.
Conclusions: Detailed surveillance of seasonal influenza reassortment patterns and variant properties may provide unique
information needed for prediction of spread and construction of future influenza vaccines.
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Influenza is one of the most important human respira-
tory infections, and its seasonal recurrence is a major
contributor to human morbidity and mortality. Seasonal
influenza has an estimated annual attack rate of 10–20%,
leading to 3–5 million cases of severe illness and
250,000 to 500,000 deaths each year [1]. Throughout
history, influenza A has been the greatest contributor to
human pandemics. During the last century, four* Correspondence: irina.maljkovicberry.ctr@mail.mil
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society, and shaped future research and public health
policies.
The emergence and evolution of pandemic influenza
has been greatly shaped by the process of segment reas-
sortment occurring between different influenza subtypes,
a process that enables swift changes of viral antigenic
properties and may generate variants to which there is
little to no immunity in the general population [2–4]. In
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ity of the virus, substantially increasing its ability to
quickly adapt to changing environments [5–7]. However,
the process of inter-subtype reassortment may be re-
stricted by substantial segment incompatibility, resulting
in lower viral fitness and in limited success of reassor-
tant spread in the human population [8, 9]. Indeed, des-
pite high estimates of influenza reassortment capability,
relatively few inter-subtype reassortants have actually
established sustained human infections [7, 10–13].
Unlike inter-subtype reassortment, reassortment be-
tween different lineages of the same influenza subtype
(intra-subtype) may not be as restricted due to higher
genetic relatedness and functional compatibility of their
segments [14, 15]. Like inter-subtype reassortment, how-
ever, intra-subtype reassortment plays a crucial role in
increasing viral genetic diversity and adaptation plasti-
city [16–20]. The importance and the impact of influ-
enza intra-subtype reassortment extend to all aspects of
the influenza virus, from its evolution to its spread,
disease severity, and vaccine efficacy. For instance, reas-
sortment events within the influenza H1N1 subtype
triggered the emergence of unusually severe seasonal
epidemics of 1947 and 1951, and reassortment within
the seasonal H3N2 influenza led to the dramatic rise
and worldwide spread of resistance to adamantine drugs
[21, 22]. In 2003, reassortment between two antigenically
distinct lineages of H3N2 caused a major change in viral
antigenic properties, leading to poor vaccine match and
reduced vaccine effectiveness [23, 24]. Intra-subtype reas-
sortment of H3N2 has also been shown to temporarily in-
crease the rate of adaptive amino acid replacements within
the reassorted variants and to be the major determinant of
this virus’s evolution, superseding the contribution of
adaptive processes caused by drift [17, 18, 20, 23, 25, 26].
As the role of influenza virus intra-subtype reassort-
ment becomes increasingly apparent, identification and
surveillance of its occurrence become ever more import-
ant. In general, detection of influenza virus reassortment
requires screening of segment phylogenetic trees, where
tree incongruences point to differences in segment
evolutionary history. Until recently, intra-subtype reas-
sortment has been studied by manual comparisons of
segment phylogenies, a highly time-consuming task im-
posing restrictions on the size of the data and the depth
and detail of the analyses. In addition, higher relatedness
of sequences from the same subtype leads to a less
pronounced phylogenetic signal, making detection of
recent and subtle reassortments particularly challen-
ging [21, 23, 27, 28]. The latest developments in au-
tomated tools for detection of influenza reassortment
have allowed for bigger and more thorough analyses
and, by accounting for uncertainties in inferred phy-
logenies, have also made the identification of bothinter- and intra-subtype reassortment a more robust
process [10, 18, 20, 25, 28–30]. This has contributed
to our understanding of the occurrence and the import-
ance of influenza intra-subtype reassortment; however, a
clear picture of influenza intra-subtype reassortment and
its influence throughout the world is still missing. In this
study, we utilize the latest advanced approaches in com-
bination with more conventional phylogenetic analyses to
determine the frequency of H3N2 intra-subtype reassort-
ment in the human population, as well as to investigate its
implications on virus evolution, transmissibility, spread,
and vaccine efficacy and prediction.
Methods
Sample collection, sequencing, and genome construction
Following combined surveillance efforts by the Department
of State (DoS), Armed Forces Research Institute of Medical
Sciences (AFRIMS), Naval Health Research Center
(NHRC), Naval Medical Research Unit 6 (NAMRU-6),
United States Air Force School of Aerospace Medicine
(USAFSAM), and Walter Reed Army Institute of Research
(WRAIR), 151 H3N2 influenza nasal or throat swabs were
collected following Influenza-Like Illness (ILI) surveillance
protocols. The samples were collected from different loca-
tions of the world between years 2009 and 2014. Primary
isolates were made in Madin-Darby canine kidney
(MDCK) cells either at WRAIR or in a host country la-
boratory as part of standard diagnostic procedures. All the
samples and isolates were sent to WRAIR where viral
RNA was extracted using QIAamp Viral RNA Mini Kit
(Qiagen, Cat. number 52906).
For samples acquired before 2012, whole genome
complementary DNA (cDNA) was generated using RT-
PCR, and DNA was amplified by nested PCR using 48
pairs of fusion primers (H3N2-specific) with 454 adaptors
and barcodes attached to the 5’ ends (Additional file 1).
DNA was purified using the QIAquick PCR Purification
Kit (Qiagen, Cat. number 28106) and quantified using an
Agilent DNA1000 chip. An equal amount, 500 ng in total,
of DNA of each sample (up to 96 samples) was pooled to-
gether for downstream rapid library preparation, emulsion
PCR amplification (Lib-L, Large volume kit), and titanium
sequencing (Roche 454 FLX + system), following manufac-
turers’ protocols.
For samples acquired between 2012 and May 2014,
whole genome viral RNA was translated into first strand
cDNA using SuperScript III reverse transcriptase
(Invitrogen, Cat. number 18080044), and the DNA amp-
lification was performed using the Platinum Taq DNA
Polymerase High Fidelity System (Invitrogen, Cat. num-
ber 11304–102) according to manufacturers’ protocols.
A single pair of universal primers and eight pairs of
segment-specific primers were used for the two-step RT-
PCR (Additional file 1). PCR products were loaded onto
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check DNA quality. Segments for the same samples were
pooled together, and the DNA was purified using the
QIAquick PCR Purification Kit (Qiagen, Cat. number
28106). 500 ng of each sample was sonicated, and the
454 adaptor and barcode were ligated before proceeding
to rapid library preparation, emulsion PCR amplification,
and titanium sequencing (Roche 454 FLX + system).
Gaps and low sequence coverage were filled by Sanger
sequencing using the BigDye Terminator v3.1 Cycle
Sequencing Kit (ABI, 4337456) on the ABI 3130XL
Genetic Analyzer. For 9 samples collected between 2012
and 2014, the purified DNA was quantified with a Nano-
Drop 1000 Spectrophotometer, and 1 μg of each sample
was fragmented using a Covaris S2 sonicator. Libraries
with unique barcodes were made with the Ion Plus
Fragment Library Kit (ABI, Cat. number 4471252)
following manufacturer protocols. Libraries were quanti-
fied and pooled together for emulsion PCR using the Ion
One Touch 200 Template Kit (ABI, Cat. number
4478316). Enriched template-positive libraries were se-
quenced using the Ion PGM 200 Sequencing Kit (ABI,
Cat. number 4474004) and an Ion 316 Chip.
For samples acquired after May 2014, two-step RT-
PCR was performed as described above using the same
primers (Additional file 1). PCR products were loaded
onto 1.0% agarose gel and electrophoresis was per-
formed to check DNA quality. Segments for the same
samples were pooled together, and the DNA was purified
using the QIAquick PCR Purification Kit (Qiagen, Cat.
number 28106). Purified DNA was quantified using the
Quant-iT PicoGreen dsDNA Assay Kit (Invitrogen, Cat.
number P11496). The DNA in each sample was diluted
to 0.2 ng/μl prior to library preparation based on its
PicoGreen reading. Following the manufacturer’s proto-
col, 5 μl of DNA (1 ng per sample) was used as start ma-
terial for library preparation (Nextera XT DNA Sample
Preparation Kit, Cat. number FC-131-1096). Libraries
were normalized, pooled together, and loaded onto the
MiSeq sequencing reaction cartridge (MiSeq Reagent kit
v2, 500 cycles, Cat. number MS-102-2003) for sequen-
cing. Genomes were constructed from raw fastq and sff
files generated by the sequencing instruments using the
ngs_mapper v1.2, an in-house developed reference map-
ping pipeline [31]. All genomes were submitted to
GenBank under accession numbers [GenBank:KT88
8068]–[Genbank:KT889275].
Sequence dataset compilation
In April 2014, all available, complete genome sequences
of influenza H3N2, sampled between 2008 and 2013,
were downloaded from the Influenza Virus Resource
(IVR), the Influenza Research Database, and the Global
Initiative on Sharing All Influenza Data (GISAID)EpiFluTM Database [32–34]. This also included 18 full
genome vaccine and vaccine candidate sequences sam-
pled between 2005 and 2013, 11 full genome sequences
belonging to the CA04 and PE09 antigenic clusters [20],
and 5 full genome sequences sampled between 1977 and
1987 (to be used as an outgroup). No full genome se-
quences were available at that time point for year 2014
in any of the databases. The quality of the obtained se-
quences was evaluated using several steps, including the
IVR annotation tool, alignment, and phylogenetic infer-
ence; sequences with unexpected stop codons, consecu-
tive Ns, unusual frame shifts and indels, and those with
very long branches in trees were removed from the data-
set. This high-quality dataset comprised 2154 database-
derived full genomes with known sampling dates and
locations. From these, the H3N2v sequences [35, 36]
were removed, resulting in a dataset of 1940 full ge-
nomes. All WRAIR and downloaded sequences were
pooled into one single dataset, comprising a total of
2091 H3N2 full genomes (accession numbers for refer-
ence genomes are listed in Additional file 2).
Phylogenetic inference
Separate sequence alignments were made for all 8 influ-
enza segments, containing all 2091 sequences each,
using MAFFT v7 and manually examined in MEGA v6
[37, 38]. In addition, a full genome alignment was com-
piled by concatenation of all 8 segments. The best-fit
model of evolution for each of the segments was deter-
mined using jModelTest v2.1.7 based on the Akaike
information criterion (AIC) [39]. Maximum likelihood
(ML) phylogenetic trees for each of the segments, and
for the full genome, were inferred using PhyML v4.9.1
[40, 41]. The model of evolution used for the full gen-
ome tree inference was GTR+I+Γ (general time revers-
ible with empirically estimated proportion of invariant
sites and gamma distribution of among-site variation, 4
categories) [42–44], as it was the most complex model
found for some of the segments. The tree space was
searched heuristically using the best of NNI (nearest
neighbor interchanges) and SPR (subtree pruning and
regrafting). Node confidence values were determined by
aLRT (approximate likelihood-ratio test) using the non-
parametric Shimodaira-Hasegawa approach [45]. All
trees were rooted by the 5 outgroup genomes (sampled
1977–1987). In addition, all vaccine genomes, genomes
belonging to a known antigenic cluster (CA04 and
PE09) and genomes sampled between 1977 and 1987
were removed from the full dataset (N = 34). This re-
duced dataset (N = 2057) was randomly subsampled 20
times creating 20 smaller data subsets, containing be-
tween 251 and 261 randomly sampled genomes. To each
of these, all the 34 removed genomes were added back,
to serve as a consistent reference in downstream
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ments each. The Metropolis-coupled Markov chain
Monte Carlo (MCMC) algorithm with 2 runs and 4
chains, as implemented in MrBayes v3.2 [46], was used
to sample trees for all 160 alignments. The chains were
run for 50 million generations, with a burn-in of 25%
and a sampling frequency of 25,000, utilizing evolution-
ary models previously estimated by jModelTest.
Reassortment detection
For every one of the 20 data subsets used in MrBayes,
all segment tree files, with 2000 sampled trees each,
were compared and searched for phylogenetic incongru-
ences and reassortment events using a biclique enumer-
ation algorithm with phylogenetic discordance test, as
implemented in the Graph-incompatibility-based Reas-
sortment Finder (GiRaF) v1.02 [28]. The burn-in was set
to 25%, and resulting reassortment events with confi-
dence levels >0.9 were considered accurate. The 34
shared reference genomes recurring in each of the data
subsets, together with some repeatedly randomly sam-
pled sequences, also aided in confirmation of reassortant
groups/events. However, we were aware that some of the
genomes from the big dataset (N = 2057) might not have
been sampled by chance, and their possible involvement
in reassortment would remain unresolved. Thus, all reas-
sortants were mapped onto the maximum likelihood (ML)
segment and full genome phylogenetic trees (inferred by
using all 2091 genomes) and visualized using FigTree [47].
Manual investigation of the genome movement across the
segment ML trees allowed for confirmation or rejection of
complex and unresolved reassortment patterns found by
GiRaF. Investigation of the full genome ML tree resulted
in a more confident assignment of genomes not randomly
sampled in any of our 20 data subsets and genomes not
properly assigned because of low phylogenetic signal, as
well as final identification of reassortant clades represent-
ing viruses generated from the same reassortment event
(designated as lineages I-XVI). For instance, as all reassor-
tant genomes belonging to a group found by MrBayes/
GiRaF analyses clustered together in a highly supported
clade in the full genome tree, any unassigned genomes
also found within this clade could correctly be categorized
as belonging to the same reassortment event. Thus, a reas-
sortant clade/lineage was defined as the smallest clade
within which all identified reassortants were found. In
addition, manual investigation of the full dataset segment
ML trees (Additional files 3, and 4) allowed for identifica-
tion of false positive reassortant clades. Because GiRaF de-
termines reassortment events by detecting incongruences
between the segment trees, reassortant groups/clades will
be detected if they occupy different positions in different
segment trees. However, movement of one clade can re-
sult in displacement of another clade in a tree, without thelatter one being a true reassortant. Careful examination of
the segment phylogenetic trees revealed this to be the
case, and the false positive reassortants detected by GiRaF
were removed from the results. In the end, only reassor-
tants confirmed by both MrBayes/GiRaF and ML tree
inspections were accepted.
RDP analyses
Recombination Detection Program version 4 (RDP4)
[48] was used to confirm reassortment events detected
using MrBayes/GiRaF and ML. Given that we were
specifically investigating full segment reassortment
events rather than intra-segment recombination, the
concatenated full genomes were constructed and the re-
combination events were required to be significantly
supported (p value <0.05) by at least 3 of the 8 methods
employed within the RDP4 package. To minimize com-
putational burden and allow for timely recombination
analyses, all sequences belonging to the GiRaF-detected
reassortant clades/lineages were removed from the align-
ment, and their ancestral sequences, inferred by the joint
ancestral sequence reconstruction (ASR) in HyPhy [49]
(reassortants of reassortants not included), were added
instead.
Reassortment frequency
The frequency of H3N2 intra-subtype reassortment for
2008–2014 was calculated for both the 20 separate data
subsets generated by the MrBayes/GiRaF analyses and
for the dataset as a whole generated by a combination of
MrBayes/GiRaF and ML analyses. The frequency of reas-
sortment events was estimated as the total number of
reassortant groups/events and unique reassortants, di-
vided by the number of all genomes. The fraction of
reassortant genomes was estimated as the total number
of reassortant genomes divided by the number of all ge-
nomes. The 34 recurring genomes were not included in
these calculations.
Evaluation of continuous reassortment was performed
on 15 of our identified reassortant clades/lineages, ex-
cluding lineage II because of its association with regional
and temporal sampling limitations. Instead, the large
Texas/50/2012 vaccine-associated clade/lineage was
included, as it contained the most recently sampled se-
quences and was of non-reassortant origin. Frequency of
continued reassortment was calculated as the number of
reassortment events within a lineage divided by the total
number of genomes within that lineage/clade. The num-
ber of reassortment events was weighted to correctly
estimate the contribution of inter-lineage reassortant ge-
nomes. All reassortant genomes with all of the segments
originating from within a lineage contributed with a
score of 1 for that lineage. Inter-lineage reassortants
contributed with a score of 1 divided by the number of
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if a lineage had 3 within-lineage reassortants, and an
additional 2 reassortants with some segments originating
from that lineage and the rest from another one, the
total reassortment score for the lineage in question
would be 3 + 1/2 + 1/2 = 4.
For comparison of reassortment frequencies be-
tween different reassortant and/or non-reassortant
clades, we used z-test. However, z-test could not be
used on clades that consisted of very few genomes
and where this frequency was 0. Thus, we performed
a chi-squared test comparing the number of observed
reassortment events to the number of expected reas-
sortment events given the previously estimated reas-
sortment frequency of 3.35%.
Adjustment for sampling bias towards North America,
where approximately half of the genomes originated, was
made by randomly subsampling the North American
dataset 10 times such that each of the 10 data subsets
contained 300 genomes each from this region. The full
dataset (N = 2091) was stripped from all North American
genomes, and this reduced set was added to the 10
North American random subsets. The frequency of reas-
sortment events and the fraction of the reassortant
genomes were calculated for each of the subsets as
described above.
Timing of reassortment events
Bayesian Evolutionary Analysis Sampling Trees (BEAST
v1.8) [50] was used to estimate the time of formation of
the 16 reassortant lineages/clades. Because of the size of
the full dataset, which was too large for timely analyses
with BEAST, three smaller datasets were constructed
that included all reassortant genomes belonging to the
groups/clades of interest and 200 randomly sampled se-
quences from the rest of the data. The 5 genomes sam-
pled between 1977 and 1987 were also included. The
first dataset (BEASTA) consisted of 359 sequences from
the reassortant clade X and 200 randomly sampled
sequences (N = 559), the second dataset (BEASTE) in-
cluded 183 sequences from the reassortant clades II,
III, XI, and XII and 200 randomly sampled sequences
(N = 388), and the third dataset (BEASTF) had 216
sequences from the reassortant clades I, IV, V, VI, VII,
VIII, IX, XIII, XIV, XV, and XVI and 200 randomly
sampled sequences (N = 421). All 8 segments from the
three smaller datasets were analyzed. The Markov
Chain Monte Carlo (MCMC) chains were run for 500
million generations, sampling every 50,000, with a
strict clock and Bayesian skyride with Gaussian
Markov Random Field (GMRF) smoothing prior.
Models of nucleotide evolution were used as esti-
mated by jModelTest v2.1.7. In cases where the
resulting evolutionarily stable strategy (ESS) valueswere low (<200), we preformed three separate MCMC
runs and combined the results. In three instances, the
strict clock had to be replaced by an exponential or
lognormal one to achieve convergence. All the XML
files (without sequence data due to GISAID restric-
tion of data sharing) and a table of seeds for each
run are available in Additional file 5. The time of creation
of a certain reassortant was determined by the time of the
most recent common ancestor (TMRCA) of its youngest
segment, i.e., the segment with the most recent genetic
sweep [18]. The segment TMRCA differences of a lineage
were also used to confirm the reassortant nature of that
lineage. In addition, the three BEAST datasets described
above were used for (1) confirmation and reassortment
pattern determination of the reassortant lineages by
assigning lineage-specific discrete traits to the genomes
comprising these lineages [10] and (2) phylogeographic
analyses where discrete traits were represented by the re-
gion of sampling of a genome. However, these datasets
proved too big for confident and timely discrete trait ana-
lyses and provided only fragmented information.
Amino acid and entropy analyses in global and local
lineages
In order to investigate differences between the 16 differ-
ent reassortant clades/lineages, we divided them into
different groups based on the following criteria. (1) Glo-
bally spread lineages (Global) were those where genomes
were sampled from at least four different regions of the
world and where one region contributed with less than
80% of the total number of sampled reassortant ge-
nomes. (2) Locally spread lineages were those where
80% or more of the reassortant genomes were sampled
from the same region. Locally spread lineages were fur-
ther divided into high (High Local) or low (Low Local),
where High Local variants were the ones represented by
>10% of all samples from that region. Using these cri-
teria, the reassortant lineage/clade II was assigned High
Local; however, it was excluded from the final compari-
son analyses as it contained the only sequences (locally
sampled) available for year 2014. Because of uneven
sampling of the downloaded influenza genomes, we
assigned our geographical distribution with low reso-
lution, and the regions were defined on continent geo-
graphic scale as North (N) America, South-Central (SC)
America, Europe, Asia, Australia and Oceania, and Mid-
dle (M) East. Raw amino acid differences were compared
for all viral proteins (HA, M1 and M2, NA, NP, NS1 and
NS2, PA, PB1 and PB1_F2, and PB2) between Global
and High Local reassortants, High Local and Low Local
reassortants, and in between High Local reassortants
from different regions of the world. Shannon entropy
differences [51] were assessed for amino acid positions
of all viral proteins between Global and High Local
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High Local reassortants from different regions of the
world. Low Locals were excluded because of low num-
bers resulting in low statistical power. Furthermore, to
circumvent false negative results due to a low number of
genomes in some of the tested reassortants, all Global
reassortants were together compared to all High Local
ones (grouped comparisons), and the positions found
significant in both grouped and pairwise tests were ex-
amined for their amino acid compositions. Clade/lineage
II was removed from the latter analyses.
Selection analyses
In order to detect differences in positive selection be-
tween Global and High Local lineages, we investigated
presence of positive selection in HA, NA, and PB2 cod-
ing regions of Global and High Local alignments separ-
ately, using several different approaches available in
HyPhy: SLAC (Single Likelihood Ancestor Counting),
FEL (Fixed Effects Likelihood), and FUBAR (Fast Un-
constrained Bayesian Approximation) [49]. For SLAC
and FEL, a p value <0.05 was used as significance cut-
off, and for FUBAR a posterior probability >95 was used.
Because certain nucleotide positions in some of our
genomes consisted of International Union of Pure and
Applied Chemistry (IUPAC) symbols for ambiguous
nucleotides, and because HyPhy handles such cases as
partially missing data, there was a risk of missing poten-
tially important variation by not including the informa-
tion found in the ambiguous positions. Thus, sequences
with ambiguous nucleotide positions were duplicated
and the positions in question changed to the existing
variants as indicated by the IUPAC code, such that all
existing original sequence variation was represented in
the alignment. Outlier sequences (three from HA align-
ment and one from NA) with more than three ambigu-
ous positions in each of the genes were not included in
these analyses.
Passaging analyses
In order to investigate whether passaging of isolates in
MDCK affected our results for position NA 151, we col-
lected all available passaging information from GenBank
or GISAID for the reassortant isolates in this study. In 8
out of 13 local lineages the majority of isolates had avail-
able passaging history (Additional file 6). None of the
global lineages contained enough viruses with available
passaging information. However, one lineage that was
predicted to be Global by our study, lineage II, did have
enough passaging information and was thus used for
statistical analyses against the Local lineages. Samples in
each lineage were divided into two categories: not pas-
saged + passaged in eggs (since egg passaging does not
affect the composition of NA position 151) and passaged(including MDCK1, MDCK2, MDCK3, C1, C2, C3,
RhMK1).
Results
Reassortment identification reveals the extent of its
complexity
The dataset used in this study comprises 2091 H3N2 full
genomes sampled from 56 different countries between
2008 and 2014. Identification of reassortment was
performed by combined MrBayes/GiRaF and ML ana-
lyses of segment tree incongruence, where reassortant
genomes found in MrBayes/GiRaF analyses were
mapped onto the ML segment trees, and the results
were used for confirmation of reassortment. Following
this, the found reassortants were mapped onto a full
genome ML tree, which was used for determination of
reassortant lineages with reliance/confidence, and for fur-
ther refined detection of genomes within these lineages
(Fig. 1). There were a total of 16 reassortant clades/line-
ages found (I to XVI, Fig. 1, Table 1). Each of these line-
ages represented a single reassortment event followed by
subsequent spread and sampling of the reassortant virus
in the human population. Each of the reassortant lineages
in the full genome ML tree (Fig. 1) was supported by high
node confidence values (approximate likelihood-ratio
test, aLRT >0.7). In several instances, one reassortant
clade/lineage was found within another, indicating the
presence of second-generation reassortment (lineages
XI, XII, XV, and XVI). As noted previously, mono-
phyly of reassortant clades was not always observed
in the separate segment trees [25, 28].
In addition to 16 reassortant clades/lineages, 53 ge-
nomes were found with unique reassortment patterns,
and 4 additional genomes were identical to 4 of these
unique reassortants. These genomes represented reas-
sortant viruses that did not establish a successful spread
in the human population. Some of these unique reassor-
tants had segments derived from within the second-
generation reassortant lineages, demonstrating the
occurrence and detection of third-generation reassort-
ment. Ten of the genomes showed more complex reas-
sortment patterns of segment exchange, including
segments originating from at least three different paren-
tal lineages/clades. Most, but not all, of the reassortants
were also confirmed using RDP (Table 2). RDP is in
general used to find parental genomes of recombinant
sequences, and lack of their presence might have re-
sulted in reassortment underestimation by this tool [48].
RDP also found a large amount of reassortment where
none existed (169 false positive genomes), as compared
by manual examination of the trees and GiRaF results.
This has been observed in RDP previously [28].
Thus, we identified a total of 805 reassortant genomes
in our dataset. These were a result of 69 different
Fig. 1 (See legend on next page.)
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Fig. 1 Reassortant lineages and variants found among H3N2 genomes sampled between 2008 and 2014. The full genome maximum likelihood
phylogenetic tree shows 16 reassortant clades/lineages highlighted in Baby Blue (I), Dark Blue (II), Light Blue (III), BlueD (IV), GreenD (V), GreenL
(VI), Green (VII), Dark Green (VIII), Salmon (IX), Red (X), Maroon (XI), Dark Red (XII), Orange (XIII), Purple (XIV), Lavender (XV), and Pink (XVI) (in the
order of appearance in the tree) and single reassortants marked in yellow. Vaccines and important vaccine candidate names are positioned next
to their approximate position in the tree. Years of vaccine use are in parentheses next to the vaccine names. The three most distinct non-
reassortant clades are named in black text. All reassortant and vaccine clades had node confidence values >0.7 (aLRT)
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lineages and 53 unique reassortants. We found the pres-
ence of both continued reassortment in the already reas-
sorted lineages and of reassortment variants with their
segments derived from three or more different parents.
H3N2 intra-subtype reassortment exhibits stable event
frequency
By dividing the number of reassortment events by the
total number of influenza genomes, we estimated the
frequency of H3N2 intra-subtype reassortment (during
years 2008–2014) for both the 20 smaller data subsets
used in MrBayes/GiRaF (MCMC) analyses, and for the









I (Baby Blue) 4 2012 2011.8 (2011.5-2011.9) 0.5 (0-
II (Dark Blue)e 20 2013-2014 2012.5 (2012.2-2012.8) 0.7 (0.5
III (Light Blue) 103 2010-2013 2009.7 (2009.6-2009.8) 3 (2.64
IV (BlueD) 25 2011 2010.3 0.5 (0-
V (GreenD) 11 2012 2011.5 (2011.2-2011.7) 0.5 (0-
VI (GreenL) 5 2012 2011.3 (2011-2011.7) 0.47 (0
VII (Green) 85 2010-2011 2009.2 (2009-2009.3) 1 (0.5-
VIII (Dark Green) 8 2010 2009.7 (2009.4-2009.8) 0.5 (0-
IX (Salmon) 13 2010 2009.3 (2009-2009.5) 0.5 (0-
X (Red) 351 2010-2012 2008.8 (2008.3-2009.1) 2 (1.54
XI (Maroon) 46 2012-2013 2011.1 (2010.9-2011.3) 1 (0.5-
XII (Dark Red) 14 2011-2013 2010.9 (2010.6-2011.4) 2 (1.57
XIII (Orange) 15 2010-2011 2009.1 (2009-2009.2) 1 (0.5-
XIV (Purple) 40 2009 2007.8 (2007.4-2008.1) 0.5 (0-
XV (Lavender) 5 2009 2008.6 (2008.3-2008.9) 0.5 (0-
XVI (Pink) 3 2009 2008.9 (2008.7-2009) 0.5 (0-
Yellow
(single unique)f
53 + 4 2008-2013
Total 805
aThe 7 recurring reassortant vaccine genomes (see Methods) were not counted
bHPD highest posterior density intervals
cRefers to the period of time when the lineage was observed in the human popula
dRefers to the total lifespan of the reassortant variant in question
eAlthough assigned High Local by the criteria, it cannot with certainty be regarded
f4 genomes were identical to 4 of the unique reassortants
gSampling lag is defined in the “Between-lineage and vaccine clade reassortment d
*All genomes were sampled in the same year with no exact dates. Thus, the persistanalyses. The average frequency of reassortment events
in the smaller data subsets was comparable to the fre-
quency of the full dataset, 3.45% and 3.35%, respectively
(Table 3a). The fraction of all the reassortant genomes in
the full dataset was 39.1%, and in the 20 smaller subsets
it averaged at 41.3% (Table 3a). We also observed high
variation of frequency values between the individual
small data subsets. This was a result of both (1) false
positive reassortment events in some subsets, which
resulted in reassortment overestimation, and (2) lack of
phylogenetic signal for confident resolution of reassort-
ment patterns in other subsets, resulting in reassortment
underestimation. These results highlight the limitations







Global High Local Low Local
1)* 0.7 (0.1-1.5) 0.2 N America
3-0.87) 1.7 (1.23-2.17) 1 M Easte
-3.36) 3.8 (3.34-4.26) 0.8 Yes
1)* 1.2 (0.7-1.7) 0.7 Asia
1)* 1 (0.3-1.8) 0.5 N America
.27-0.67) 1.2 (0.6-1.7) 0.7 Australia
1.5) 2.3 (1.7-3) 1.3 SC America
1)* 0.8 (0.2-1.6) 0.3 SC America
1)* 1.2 (0.5-2) 0.7 SC America
-2.46) 3.7 (2.94-4.66) 1.7 Yes
1.5) 2.4 (1.7-3.1) 1.4 N America
-2.43) 2.6 (1.67-3.33) 0.6 Yes
1.5) 2.4 (1.8-3) 1.4 Asia
1)* 1.7 (0.9-2.6) 1.2 N America
1)* 0.9 (0.1-1.7) 0.4 N America
1)* 0.6 (0-1.3) 0.1 N America
tion
as such due to low regional and temporal sampling
espite limited reassortant lifespan” subsection of Results
ence was given a value of 0.5, given the sampling uncertainty of 6 months




RDP [68] GENECONV [69] Bootscan [70] Maxchi [71] Chimera [72] SiSscan [73] PhylPro [74] LARD [75] 3Seq [76]
I (Baby Blue_Ancestral) NS 1.16E-02 0.026402 3.68E-06 4.39E-02 3.29E-05 NS NS 5.77E-09
II (Dark Blue_Ancestral)a 4.92E-02 NS 4.95E-02 NS NS NS NS NS NS
VI (GreenL_Ancestral)a NS NS NS 1.17E-03 NS NS NS NS 2.40E-02
IX (Salmon_Ancestral) NS NS NS 3.02E-04 1.72E-04 8.99E-06 NS NS 2.09E-11
X (Red_Ancestral) 1.81E-02 NS 1.82E-02 NS NS 1.35E-02 NS NS NS
XI (Maroon_Ancestral) 1.81E-02 NS 1.82E-02 NS NS 1.35E-02 NS NS NS
XII (Dark Red_Ancestral) 1.81E-02 NS 1.82E-02 NS NS 1.35E-02 NS NS NS
XIV (Purple_Ancestral) NS NS NS 2.00E-02 NS 9.47E-12 NS NS 5.74E-04
XV (Lavender_Ancestral) NS NS NS 2.00E-02 NS 9.47E-12 NS NS 5.74E-04
XVI (Pink_Ancestral) NS NS NS 2.00E-02 NS 9.47E-12 NS NS 5.74E-04
aTrend of recombination, only 2 out of 3 required methods showed recombination
NS - not significant
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interpretations.
To further confirm the estimates of the H3N2 intra-
subtype reassortment frequency, and to adjust for sampling
bias towards North America in the full dataset, we subsam-
pled genomes from North America such that their num-
bers approximately matched the numbers of genomes
sampled in Asia and South America. Ten of these equalized
datasets were made (Table 3b). The average frequency of
reassortment events for the equalized datasets was compar-
able to the frequency of the full dataset (3.21% and 3.35%,
respectively) and not significantly different from the fre-
quency found in the 20 smaller MrBayes datasets (t test,
p > 0.05). However, the fraction of total number of reassor-
tant genomes in the equalized datasets was estimated at an
average of 53.1%, significantly higher than the fraction in
the MrBayes datasets (t test, p < 0.01).
Since our data revealed the presence of second- and
third-generation reassortment, we investigated whether vi-
ruses belonging to a certain reassortant clade/lineage con-
tinued reassorting more efficiently/often than viruses from
other reassortant or non-reassortant clades. Analyses of 15
reassortant clades/lineages and 1 non-reassortant lineage
revealed between 0 and 19.8 first-, second-, and third-
generation reassortment events per lineage, with the num-
ber of events increasing with the lineage size (Spearman’s
rank correlation, rho = 0.84, p < 0.01) (Fig. 2). The fre-
quency of reassortment events did not differ significantly
between the clades/lineages, regardless of lineage reassort-
ment history, evolution, or geographical location, nor did it
deviate significantly from the previously estimated fre-
quency of 3.35% (z-test, p > 0.05; chi-squared test, p > 0.05).
Thus, the number of H3N2 intra-subtype reassortment
events within a lineage depended on the number of ge-
nomes in that lineage and occurred with a steady frequency
of 3.35%. It was not affected by the differences in lineagegeographic backgrounds or their previous history of
reassortment.
Between-lineage and vaccine clade reassortment despite
limited reassortant lifespan
Examination of sampling times of the genomes belong-
ing to the 16 reassortant lineages revealed that all reas-
sortant lineages did not exist simultaneously, but rather
replaced each other over time. An average of 5.4 differ-
ent reassortant lineages were found spreading during the
same years, ranging from 3 in 2009 to 7 in 2010 and in
2012. The average lifespan of a reassortant lineage was
0.9 year, with some larger reassortant clades persisting
2–3 years (Table 1). Reassortant lineages spreading glo-
bally had a significantly higher persistence (2.33 years)
than the locally spreading ones (0.63 year, p = 0.03, t
test). In general, a reassortant was sampled in the year
following the year of its formation, with an average of
0.81 year of lag time between reassortant formation and
its sampling on the population level (sampling lag), and
with no significant difference in lag time between glo-
bally and locally spreading lineages (p > 0.05, t test).
The patterns of segment exchange differed vastly be-
tween the reassortant lineages. Origins of viral segments
were generally easier to determine for between-lineage
reassortants occurring later in time, and for those with
segments originating from only two different parents.
Although GiRaF performed well in identification of the
patterns of segment exchange in these reassortants, we
observed the occurrence of fragmented and fused pre-
dictions in variants/lineages with complex reassortment
histories [28]. Fragmented predictions were generally
observed in reassortant variants that derived their seg-
ments from three or more different parental viruses or
in variants from second- and third-generation reassort-
ment. In these cases, a reassortant found by GiRaF
Table 3 Frequency of reassortment
Dataset Total genomes (N)a Reassortant genomes (N) Fraction of reassortants Reassortment events (N) Event frequency
a) Frequency calculated on the 20 MrBayes + GiRaF subsets and the full dataset
Subset 1 257 61 0.237 9 0.035
Subset 2 254 83 0.327 9 0.035
Subset 3 259 64 0.247 12 0.046
Subset 4 261 159 0.609 9 0.034
Subset 5 257 174 0.677 10 0.039
Subset 6 256 143 0.559 10 0.039
Subset 7 259 165 0.637 6 0.023
Subset 8 252 72 0.286 8 0.032
Subset 9 261 84 0.322 14 0.054
Subset 10 258 75 0.291 9 0.035
Subset 11 257 175 0.681 9 0.035
Subset 12 259 163 0.629 8 0.031
Subset 13 258 83 0.322 7 0.027
Subset 14 255 61 0.239 10 0.039
Subset 15 256 68 0.266 11 0.043
Subset 16 251 80 0.319 7 0.028
Subset 17 256 79 0.309 9 0.035
Subset 18 251 35 0.139 7 0.028
Subset 19 254 153 0.602 8 0.031
Subset 20 258 143 0.554 5 0.019
Average 256.45 106 0.4126 8.85 0.0345
SD 0.1752 0.0077
Full set 2057 805 0.3913 69 0.0335
b) Frequency calculated on the 10 data subsets adjusted for unequal sampling
Subset 1 1188 619 0.521 36 0.030
Subset 2 1188 626 0.527 37 0.031
Subset 3 1188 629 0.529 38 0.032
Subset 4 1188 632 0.532 39 0.033
Subset 5 1188 631 0.531 41 0.035
Subset 6 1188 639 0.538 42 0.035
Subset 7 1188 632 0.532 37 0.031
Subset 8 1188 628 0.529 37 0.031
Subset 9 1188 633 0.533 36 0.030
Subset 10 1188 635 0.535 38 0.032
Average 1188 630.4 0.5306 38.1 0.0321
aExcluding the 34 recurring genomes
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reassortment patterns at the same time. Fused predic-
tions were mostly observed in second- and third-
generation reassortment and in distinct reassortment
events with very similar phylogenetic histories, resulting
in false groupings of separate reassortment events. Thus,
the exact patterns of segment exchange could not be re-
solved with certainty for some genomes and lineagesbased on GiRaF and ML analyses. Of the 8 reassortant
lineages/clades where the reassortment patterns could
be determined, 6 had their HA segments derived from
one lineage and their NA segments from another,
displaying a high level of HA-NA separation during
reassortment (Fig. 3). None of the reassortant lineages
were found to have arisen through reassortment of vi-
ruses originating from differing vaccine- and vaccine
Fig. 2 Reassortment frequency of the reassortant and non-reassortant lineages. The number of reassortment events in each of the lineages/clades
as a function of the number of genomes belonging to that clade. Data points are highlighted in color of their reassortant lineage (see Fig. 1). The
top black data point represents the Texas/50/2012 vaccine-associated non-reassortant clade. Inter-clade reassortment events were weighted
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the single reassortant genomes did contain segments de-
rived from different vaccine and vaccine candidate clades
(note arrows connecting reassortants to labeled vaccine
clades in Fig. 4). Reassortment of segments from different
vaccine-associated clades, especially when separation of
HA and NA is observed, indicates reassortment between
viruses with likely distinct antigenic properties.
Thus, shortly following their formation, several vari-
ants of H3N2 intra-subtype reassortants were able to
establish a successful spread in the human population at
the same time. Although the length of reassortant spread
was temporally limited, the spatial reassortment patterns
involved variants with history of previous reassortment
and potentially differing antigenic properties.
Positions with specific amino acid patterns and entropy
define globally spread lineages
The 16 reassortant variants that established successful
spread in the human population between 2008 and 2014
also displayed differences in their geographical distribu-
tions. Some reassortant lineages spread globally, while
others were mainly found transmitting in specific re-
gions of the world. In addition, certain regions of the
world displayed a higher presence of influenza reassor-
tant genomes than others, with the most notable differ-
ences between North America and South-Central
America, with 20.2% and 83.2% of their genomes being
reassortants, respectively (Fig. 5).
To investigate properties of the different reassortant
clades/lineages, we divided them into groups, those
spreading globally (Global) or locally, and the locally
spreading ones into high (High Local) or low (Low
Local) (Table 1, for group definitions see Methods, sub-
section: Amino acid and entropy analyses in global and
local lineages). Investigation of differences in amino acid
Shannon entropy, i.e., the amount of amino acid
variation in a certain position, revealed positions signifi-
cantly different between the global and local lineages.These positions were located in only two of the seg-
ments, HA and NA. Combining the NA results from
both types of Global versus High Local comparisons
(pairwise and grouped, see Methods), only position 151
was found to significantly vary in all three Global reas-
sortants but not in the High Local ones (Table 4). This
position was also found to be under positive selection
pressure in the Global reassortant lineages but not in
the High Local (Table 5). In addition, the number of
ambiguous nucleotide positions and the number of se-
quences containing them was significantly higher in the
Global lineages (p < <0.01 and p < <0.01, F test). In HA,
position 215 had significantly higher entropy in two of
the three Global reassortants compared to the High
Local ones (Table 4). HA position 215 was not found to
be under positive selection in any of the reassortant line-
ages; however, the adjacent position 210 was positively
selected in the Global lineages (Table 5). There were no
positions that significantly differed in their entropy and
that were specific for a certain geographical region in
any of the segments.
Examination of raw amino acids between the reassor-
tant variants revealed consistent differences in only one
of the segments: PB2. Here, positions were found where
globally spreading reassortants shared amino acids that
were not found in any of the locally observed variants
(Table 4). PB2 was also the only segment in which posi-
tions were found with region-specific amino acids
(Table 4). None of the positions in PB2 were under posi-
tive selection pressure. In addition, we did not observe
any amino acids that differentiated high and low occur-
ring reassortant variants from the same region.
Thus, the intra-subtype H3N2 reassortants that estab-
lish an effective spread within the human population
may spread globally or may be confined to certain geo-
graphical regions. Our results indicate that variants with
successful global spread share some common properties
in amino acid positions located within the HA, NA, and
PB2 segments.
Fig. 3 Reassortment origins and patterns of 8 reassortant lineages. Schematic figure of segment origins and patterns of intra-subtype reassortment of
H3N2 reassortant lineages/clades. Each lineage represents one reassortment event. Approximate segment origins for 8 of the lineages are illustrated
on a full genome maximum likelihood phylogenetic tree containing 2091 H3N2 genomes sampled between 2008 and 2014. Single unique reassortants
are colored yellow in the tree. Origins and patterns were determined from ML and GiRaF analyses
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Influenza virus intra-subtype reassortment is a common
process shown to play an important role in the evolution
and adaptability of this virus. Intra-subtype reassortment
is capable of producing epidemiologically relevant variants
with impact on virus spread, disease severity, antiviral re-
sistance, and vaccine efficacy. Detailed analyses of 2091
H3N2 full genomes sampled from different regions of the
world between 2008 and 2014 revealed an extensive pres-
ence of intra-subtype reassortment variants, comprising
39% of all the H3N2 genomes studied. The frequency of
reassortment events during this period of time was esti-
mated at 3.35%, meaning the majority of reassortantgenomes circulating in 2008–2014 were derived from a
few reassortment events that were followed by establish-
ment and successful transmission of the reassorted viruses
within the human population. Furthermore, the spreading
reassortants were found to continue reassorting, giving
rise to second- and even third-generation reassortant
viruses. The frequency of this continued reassortment did
not differ significantly from the baseline frequency of
3.35%, nor did it differ significantly between the reassor-
tant lineages or lineages with no observed history of
reassortment. The notion of a stable frequency of H3N2
intra-subtype reassortment, not affected by the geographic
and evolutionary origins of the viruses or by the presence
Fig. 4 Reassortment origins and patterns of 4 genomes with segments from different vaccine-associated clades. Schematic figure of segment
origins and patterns of intra-subtype reassortment of selected H3N2 reassortant genomes. Approximate segment origins are illustrated on a full
genome maximum likelihood phylogenetic tree containing 2091 H3N2 genomes sampled between 2008 and 2014. Single unique reassortants
are colored yellow in the tree. Origins and patterns were determined from ML and GiRaF analyses
Maljkovic Berry et al. BMC Biology  (2016) 14:117 Page 13 of 19of previous reassortment, would imply that this process
occurs steadily and continuously for at least this subtype.
The correlation between the number of reassortment
events and the total number of genomes within a lineage
might also suggest that the number of reassortment events
in an influenza season will depend on the number of in-
fected individuals during the epidemic; i.e., the bigger the
epidemic, and the more viruses that circulate in the hu-
man population, the more reassortment events may occur.
However, this possibility needs to be investigated further
with more detailed and focused studies, as the number of
sampled genomes in this study might not accurately re-
flect the number of infected individuals in an epidemic.Sampling bias of influenza genomes is a known prob-
lem that may skew results if left unaccounted for.
Indeed, the dataset used in this study suffered from the
same issue, with few genomes sampled from Africa and
many from North America. Temporal sampling differ-
ences may also exist, and the persistence of different
lineages through several influenza seasons [18, 19] may
induce another potential bias to time-based analyses.
Because of this, region- or season-specific reassortment
frequency was not estimated. Instead, lineage-specific
and a total frequency of reassortment events were calcu-
lated and showed no significant differences, thus indicat-
ing that these estimates were not affected by uneven
Fig. 5 Global distribution of the H3N2 intra-subtype reassortants. Colors correspond to the reassortant lineage/clade colors in the maximum
likelihood tree (see Fig. 1). Unique reassortants are represented by yellow. Non-reassortant viruses are transparent gray. N denotes the total number
of genomes sampled from a region. Circle size is arbitrary for clarification purposes and is not proportional to N
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frequency of reassortment events in datasets that were
adjusted for sampling bias towards North America. On
the other hand, estimating the overall fraction of reas-
sortant genomes may depend on geographical sampling.
The size of this fraction in an epidemic will depend on
the success of reassortant variant transmission following
its creation, a transmission that may be affected by
vaccine efficacy, host genetics and natural immunity,
geography, or intrinsic properties and fitness of the reas-
sortant variant itself [52].
Indeed, our results show that reassortant lineages, and
thus the number of circulating reassortant genomes,
may be unevenly distributed throughout the world.
Therefore, our overall average estimate of the fraction of
reassortant genomes in the dataset as a whole may
change, as more genomes become available from under-
represented geographical regions. Confirming this no-
tion, the fraction of reassortants in the datasets adjusted
for sampling bias towards North America was signifi-
cantly different from the fraction estimated in the full
dataset and MrBayes subset analyses. Thus, making a
clear distinction between the reassortment event fre-
quency and the fraction of reassortant genomes becomes
very important, as these two measures represent differ-
ent properties of intra-subtype reassortment, and as they
are affected very differently by sampling, geography, and
time. Variations in the reassortment estimates have been
observed when viewed from seasonal and regional per-
spectives, with sometimes unexpectedly high differences
[17, 26]. These variations may be true reflections of tem-
poral changes within smaller geographical regions, or
they may be skewed if they fail to take into account the
existence of lineages through several influenza seasons.Whatever the case, these limitations result in lack of
power to reveal the general characteristics of H3N2
intra-subtype reassortment. Our study of full genomes
2008–2014 collected from most regions of the world re-
vealed a stable reassortment frequency of 3.35%, where
23% of reassortment events resulted in creation of
variants capable of establishing successful spread in the
human population.
This study used a combination of MCMC and ML seg-
ment and full genome analyses for detection of reassort-
ment. Generally, constructing full genome influenza
H3N2 phylogenies may be misleading, as concatenation
of reassorted segments results in creation of full genome
recombinant sequences, which may impact the inferred
tree topology and branch lengths. On the other hand,
genomes that share the same reassortment/recombin-
ation patterns will cluster together in a full genome tree
with higher confidence, drawn together by the strong
signal of their common reassortment/recombination an-
cestry. Furthermore, full genome trees will display better
node support due to additional genetic information
gained through segment concatenation [53–55]. These
features will allow for a more confident reassortant
lineage definition, which is especially difficult on some
H3N2 segment trees due to their low genetic diversity.
However, it is important to remember that the full
genome trees cannot be used for analyses of lineage
spatial and temporal relationships, only for refinement
of reassortant lineage identification, as utilized in this
study. The combined MCMC and ML approach thus
allowed us to more confidently estimate H3N2 reassort-
ment events. However, some events might still have been
missed due to the difficulty of reassortment identifica-
tion between strains of very similar sequences. In
Table 4 Amino acid position differences between Global and High Local reassortant lineages
Global reassortant lineage High Local reassortant lineage























NA/151 D/N/G D/N/G D/N D D/G D D D D D/N
HA/215 A/S A/S S S S S S S S S
Amino acid differences
Global vs. Local
PB2/81 I I I M M M M M M M
PB2/255 I I I V V V V V V V
PB2/392 D D D E E E E E E E
Amino acid differences
Local
PB2/221 S S A S S A A A A A
PB2/293 K K R K K R R R R R
PB2/353 K K R K K R R R R R
PB2/560 I/V I/V I/V I I V V V V V
aAlthough assigned High Local by the criteria, it cannot with certainty be regarded as such due to low regional and temporal sampling. It was included for
exploratory purposes only
D/N Position was not conserved in this reassortant lineage, and the Shannon entropy of the Global reassortants was not significantly higher in any of the
pairwise comparisons
D/G Only one of the reassortant genomes had a differing amino acid in this position. Shannon entropy of the Global reassortants was not significantly higher in
any of the pairwise comparisons
D Position was conserved in these reassortant lineages, but the Shannon entropy of the Global reassortants was not significantly higher in any of the
pairwise comparisons
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plete segment lineage sorting, resulting in an overesti-
mation of reassortment. Using all 8 segments in the
GiRaF analyses aided in the sensitivity of the reassort-
ment detection, but the above caveats still highlight the
need for development of better methodologies in this
area of research. In our analyses these limitations were
especially evident in determination of the exact patterns
of segment exchange in the already detected reassor-
tants. In fact, none of the approaches, including ML,
RDP, GiRaF, BEAST-TMRCA, or BEAST-reassortment
traits [10, 28, 30, 48], were specific, sensitive, or power-
ful enough to reveal all the specific segment exchange
patterns. The ability to track reassortment patterns of
the HA and NA segments is of particular importance, as
this can result in rapid antigenic changes and affect
vaccine efficacy.
Among the lineages in which we were able to deter-
mine patterns of segment reassortment, we did observe
frequent exchange involving the HA and NA segmentsTable 5 Amino acid positions under positive selection pressure
in Global and High Local reassortant lineages
Global High Local IIa
Method NA HA NA HA NA HA
SLAC 151 210 – – – –
FEL 151, 331 210, 505 – 277 – –
FUBAR 151, 331 210, 155, 224, 296, 505 – 277 151 –
aAlthough assigned High Local by the criteria, it cannot with certainty be
regarded as such due to low regional and temporal sampling. The lineage was
thus analyzed separatelyand, more importantly, segment exchange between vi-
ruses originating from different vaccine clades. Although
genetic clustering does not always resolve viral antigenic
differences (viruses within the same clade can have dif-
ferent antigenic properties), increasing genetic distance
does result in accumulation of antigenic distances, and
viruses clustering around different vaccine genomes in a
phylogenetic tree will most likely display differing anti-
genic properties [56–58]. Intra-subtype reassortment of
H3N2 variants with different antigenic profiles has been
observed before and resulted in a major H3N2 intra-
subtype antigenic shift and vaccine failure [23]. In our
data, we found four reassortment variants with segment
exchanges involving four major vaccine and vaccine/can-
didate clades observed between 2008 and 2014. Three of
those variants gained their HA and/or NA segments
from viruses belonging to the previous vaccine clades. If
the number of infections or vaccine efficacy from these
previous seasons was high, the general population would
already be protected from these variants, and their trans-
mission within the human population would be limited.
Indeed, all four variants represented single reassortment
events without further spread in the population. This
concurs with vaccine efficacy results for the period be-
tween 2008 and 2014, which show that the vaccines for
these seasons were close to their expected efficacy of
50–60% [59]. On the other hand, none of the spreading
reassortant lineages from our study seemed to have orig-
inated by segment exchange between different vaccine
clades, and the lack of pre-existing immunity against
these variants may have helped facilitate their spread.
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the evolution, diversity, and transmission of the influ-
enza virus. In addition, the occurrence of reassortment
between different vaccine clades involving segments of
antigenic importance demonstrates the underlying po-
tential of influenza intra-subtype reassortment to induce
swift antigenic change and highlights the significance of
an effective influenza vaccine. It is difficult to speculate
on what the low efficacy (19%) of the 2014/2015-season
Texas/50/2012 vaccine [59] may lead to, but it is inter-
esting to note that our 2014 sequences did make up a
reassortant lineage of their own. Whether the vaccine ef-
ficacy was affected by the appearance of this reassortant
lineage, or the spread of the reassortant was enabled by
the composition of the vaccine itself, remains to be un-
covered. Future analyses of vaccination rates versus tim-
ing of the reassortant spread could help shed light on
this question, but it is also possible that no relation be-
tween this reassortant lineage spread and vaccine or its
efficacy exists. Our results highlight, nevertheless, the
importance of constant surveillance and tracking of
reassortment variants, as their frequent formation and
spread presents a continuous threat.
The spreading reassortant variants found in our study
formed lineages whose existence overlapped through
time and that were able to coexist both in single and
multiple influenza seasons. Measuring the time between
a reassortant lineage’s TMRCA and the year of its sam-
pling allowed for a rough estimate of the lag time be-
tween reassortment and its detection on the population
level. Some reassortants were identified very shortly after
their formation, highlighting their rapid transmission po-
tential but also demonstrating that their early detection
is possible. Other reassortants showed considerable lag,
up to 1.7 years, between their formation and detection
at the population level. This indicates that reassortant
variants may not initially be capable of widespread trans-
mission but may exist at a very low level in the human
population. Through genetic drift, and aided by the in-
creased rate of adaptive amino acid replacements, these
can eventually attain the capability of rapid and exten-
sive spread [19, 25].
The characteristics of reassortant lineage spread varied
greatly. Some variants were able to spread globally while
others stayed mainly local, and some variants were able
to spread more successfully in a population than others.
These differences presented an opportunity to investi-
gate the possible existence of specific features that would
make a virus more fit to spread worldwide and to a high
level. Significantly higher Shannon entropy was found in
viruses from global reassortant lineages compared to
those from local lineages, in both HA and NA. Higher
variation would be expected in lineages that persist lon-
ger, as the global lineages in this study did on average. Ifrandom, this variation would not be expected to occur
in the same amino acid positions across the globally
spread lineages. This was, however, observed for two po-
sitions of the HA and NA segments. Position 215 of HA
is a previously established antibody binding site
within the antigenic epitope D of influenza virus and
has also been described as a part of a human T cell
epitope [60, 61]. In NA, position 151 has been shown
to play a role in catalytic activities and receptor bind-
ing properties of the virus, as well as drug suscepti-
bility to zanamivir [62, 63]. Higher entropy in certain
key amino acid positions of globally transmitted reas-
sortant lineages might be an inherent property of
these viruses, resulting in a greater plasticity and thus
a greater ability to adapt and overcome host and en-
vironmental global differences. Our results showed
that NA position 151 was under strong positive selec-
tion in the globally spread lineages, while no such
pressure existed in the local lineages. This may indi-
cate greater adaptation pressure on this position that
results in rapid fixation during local spread. Another
potential source of the positive selection in this pos-
ition could be extensive Madin-Darby canine kidney
(MDCK) epithelial cells passaging, which has been
suggested to increase variability of pH1N1 and pos-
sibly H3N2 NA 151 [64, 65]. Although this possibility
would need to be investigated further, we found no
significant difference between the number of passaged vi-
ruses in local and one proposed global lineage in our data
(t test, p > 0.05), suggesting that MDCK passaging was
probably not responsible for the observed difference in
variability between these lineages in this specific position.
However, we cannot exclude the possibility that the passa-
ging history of the other three Global lineages differed
from the one examined here. Further suggestive of the no-
tion of greater adaptability was the significantly higher fre-
quency of ambiguous nucleotide positions and sequences
with ambiguous nucleotide positions throughout the HA
and NA segments of globally spreading reassortants. This
finding, which would need to be confirmed in a controlled
sequencing setting, would indicate that these viruses from
the start had more existing evolutionary paths available
for adaptation due to their higher intra-population diver-
sity. No positive selection in the HA position 215 indi-
cated that it might not play as great a role in this process
as the position 151 in NA.
Interestingly, looking at the High Local reassortant
lineage II, we notice somewhat higher variability of the
NA position 151 compared to the other local reassor-
tants, as well as positive selection pressure and a higher
proportion of viruses with ambiguous nucleotide sites.
Further analyses including more genomes from 2014
and 2015 will reveal whether this reassortant lineage,
found mainly in our samples from Kuwait, indeed is
Maljkovic Berry et al. BMC Biology  (2016) 14:117 Page 17 of 19local or if it is spreading globally. The observed higher
entropy, selection, and presence of ambiguous nucleo-
tides indicate, however, that this reassortant lineage
might, at this point, be found throughout the world. Our
results also indicated a possible role of certain PB2
amino acids in the regional and worldwide spread of the
reassortant variants. Although we still lack information
on the exact role these amino acids play for the influ-
enza virus in general, other variations within PB2 have
been shown to play an important role in replication ef-
fectiveness, virulence, and fitness of influenza viruses
[66, 67]. The specific amino acid position properties of
the globally spreading reassortant variants could thus be
used for tracking and, more importantly, prediction of
future influenza spread, aiding in predictions of vaccine
efficacy and providing information crucial for construc-
tion of future influenza vaccines.
Conclusions
In summary, we show that the intra-subtype reassortment
of influenza H3N2 is a frequent and dynamic process, dis-
playing layers of properties and events that can occur and
exist at the same time. The non-discriminatory manner of
influenza reassortment is reflected by its occurrence within
and between the lineages/clades of H3N2, regardless of
the viruses’ geographical or evolutionary origins or their
previous history of reassortment. Unlike the occurrence of
reassortment events, the establishment and the spread of a
reassortant variant may not be an entirely random process.
Many factors can come to play a role in this, such as viral,
host, and environmental elements. These may not be mu-
tually exclusive but may have different degrees of effect in
different scenarios. Additionally, given the high frequency
of H3N2 intra-subtype reassortment, the appearance of
inter-vaccine clade variants comes as no surprise. The pos-
sible rapid change of the antigenic properties of these reas-
sortants may affect both disease severity and vaccine
efficiency, and it highlights the importance of detailed sur-
veillance as well as a further understanding of the process
of intra-subtype influenza reassortment.Additional files
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